CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice.
Carlo-Stella C, Guidetti A, Di Nicola M, Longoni P, Cleris L, Lavazza C, Milanesi M, Milani R, Carrabba M, Farina L, Formelli F, Gianni AM, Corradini P.
Carlo-Stella C, et al. Among authors: gianni am.
Exp Hematol. 2006 Jun;34(6):721-7. doi: 10.1016/j.exphem.2006.03.005.
Exp Hematol. 2006.
PMID: 16728276
Free article.